perjeta - pertuzumab injection, solution, concentrate
(Pertuzumab)Genentech, Inc.
Usage: PERJETA is a HER2/neu receptor antagonist indicated for adults with HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel, as well as for neoadjuvant and adjuvant treatments of locally advanced or early stage breast cancer as part of a complete treatment regimen.